全球胜肽合成市场规模、份额、趋势和成长分析报告（2026-2034）

预计胜肽合成市场将从 2025 年的 66.9 亿美元成长到 2034 年的 139.8 亿美元，2026 年至 2034 年的复合年增长率为 8.54%。

由于製药和生物技术领域的研究活动日益活跃，全球胜肽合成市场稳步成长。肽在药物开发、诊断和治疗应用中发挥着至关重要的作用。慢性病盛行率的上升正在加速对肽类药物的需求。生命科学研究投入的增加进一步推动了重点地区市场的成长。

成长要素包括固相合成技术和自动化程度的进步。製药公司在标靶治疗和个人化医疗中依赖肽类药物。化妆品配方中胜肽类药物的日益广泛应用也推动了需求的成长。此外，科学研究和政府资助也在推动合成技术的创新。

随着全球生物製药开发平臺的不断扩展，未来前景依然强劲。经济高效的合成方法的开发和纯化技术的改进将推动生产规模的扩大。精准医疗的日益普及将进一步促进胜肽类药物的应用。随着医学研究的不断深入，预计市场将持续成长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球胜肽合成市场：按类型划分

• 市场分析、洞察与预测
• 低于75%
• 75-85%
• 超过85%

第五章 全球胜肽合成市场：依产品划分

• 市场分析、洞察与预测
• 装置
• 试剂和耗材
• 其他的

第六章 全球胜肽合成市场：依技术划分

• 市场分析、洞察与预测
• 固相胜肽合成（SPPS）
• 溶液相胜肽合成（SPS）
• 液相肽合成（LPPS）
• 杂交和重组

第七章 全球胜肽合成市场：依应用划分

• 市场分析、洞察与预测
• 治疗药物
• 诊断与研究

第八章 全球胜肽合成市场：依最终用户划分

• 市场分析、洞察与预测
• 製药和生物技术公司
• 契约製造组织（CMO）或受託研究机构（CRO）
• 学术研究机构

第九章 全球胜肽合成市场：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 亚太其他地区
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第十章 竞争格局

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十一章：公司简介

• 主要公司的市占率分析
• 公司简介
  • PolyPeptide Group
  • Merck KGaA
  • Thermo Fisher Scientific
  • Enamine Ltd
  • Alfa Chemistry
  • CEM Corporation
  • GenScript
  • AAPPTec
  • Bachem Holding
  • AnaSpec Inc
  • Biotage

The Peptide Synthesis Market size is expected to reach USD 13.98 Billion in 2034 from USD 6.69 Billion (2025) growing at a CAGR of 8.54% during 2026-2034.

The Global Peptide Synthesis market has grown steadily due to increasing research activities in pharmaceuticals and biotechnology. Peptides play a critical role in drug development, diagnostics, and therapeutic applications. Rising prevalence of chronic diseases has accelerated demand for peptide-based drugs. Expanding investments in life sciences research further support market growth across major regions.

Growth drivers include advancements in solid-phase synthesis technologies and automation. Pharmaceutical companies rely on peptides for targeted therapies and personalized medicine. Increasing use of peptides in cosmetic formulations also contributes to expanding demand. Additionally, academic research and government funding enhance innovation in synthesis techniques.

Future prospects appear strong as biopharmaceutical pipelines expand globally. Development of cost-efficient synthesis methods and improved purification technologies will drive scalability. Growing focus on precision medicine will further increase peptide utilization. The market is projected to witness sustained growth aligned with advancements in medical research.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Under 75%
• 75-85%
• Above 85%

By Product

• Equipment
• Reagents and Consumables
• Others

By Technology

• Solid-Phase Peptide Synthesis (SPPS)
• Solution-Phase Synthesis (SPS)
• Liquid-Phase Peptide Synthesis (LPPS)
• Hybrid and Recombinant

By Application

• Therapeutics
• Diagnosis and Research

By End User

• Pharmaceutical and Biotechnology Companies
• Contract Manufacturing Organization (CMO) or Contract Research Organization (CRO)
• Academic and Research Institutes

COMPANIES PROFILED

• PolyPeptide Group, Merck KGaA, Thermo Fisher Scientific, Enamine Ltd, Alfa Chemistry, CEM Corporation, GenScript, AAPPTec, Bachem Holding, AnaSpec Inc, Biotage
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL PEPTIDE SYNTHESIS MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Under 75% Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. 75-85% Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Above 85% Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PEPTIDE SYNTHESIS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Product
• 5.2. Equipment Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Reagents and Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PEPTIDE SYNTHESIS MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Technology
• 6.2. Solid-Phase Peptide Synthesis (SPPS) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Solution-Phase Synthesis (SPS) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Liquid-Phase Peptide Synthesis (LPPS) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Hybrid and Recombinant Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PEPTIDE SYNTHESIS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Application
• 7.2. Therapeutics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Diagnosis and Research Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL PEPTIDE SYNTHESIS MARKET: BY END USER 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast End User
• 8.2. Pharmaceutical and Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Contract Manufacturing Organization (CMO) or Contract Research Organization (CRO) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Academic and Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL PEPTIDE SYNTHESIS MARKET: BY REGION 2022-2034(USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Type
  • 9.2.2 By Product
  • 9.2.3 By Technology
  • 9.2.4 By Application
  • 9.2.5 By End User
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Type
  • 9.3.2 By Product
  • 9.3.3 By Technology
  • 9.3.4 By Application
  • 9.3.5 By End User
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Type
  • 9.4.2 By Product
  • 9.4.3 By Technology
  • 9.4.4 By Application
  • 9.4.5 By End User
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Type
  • 9.5.2 By Product
  • 9.5.3 By Technology
  • 9.5.4 By Application
  • 9.5.5 By End User
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 South East Asia
  • 9.5.11 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Type
  • 9.6.2 By Product
  • 9.6.3 By Technology
  • 9.6.4 By Application
  • 9.6.5 By End User
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL PEPTIDE SYNTHESIS INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 PolyPeptide Group
  • 11.2.2 Merck KGaA
  • 11.2.3 Thermo Fisher Scientific
  • 11.2.4 Enamine Ltd
  • 11.2.5 Alfa Chemistry
  • 11.2.6 CEM Corporation
  • 11.2.7 GenScript
  • 11.2.8 AAPPTec
  • 11.2.9 Bachem Holding
  • 11.2.10 AnaSpec Inc
  • 11.2.11 Biotage